Introduction

17
Obesity is linked to many co-morbidities, including type 2 diabetes mellitus, cardiovascular 18 disease, certain cancers and respiratory disease.
[1] Severe and morbid obesity (BMI 19 between 35 and 39.9 kg/m 2 and ≥40 kg/m 2 respectively) sharply reduces life expectancy, 20 especially in young adults. [ 
2] 21
Bariatric surgery results in a higher degree of sustained weight loss, with reduced weight 22 related co-morbidity and mortality, compared with conventional diet and weight loss 23 strategies.
[3] The aims of the anatomical and functional changes in the proximal 24 gastrointestinal tract during bariatric surgery are to lead to impaired calorie digestion and 25 absorption at more distal segments.
[1] Consequent alterations in micro-nutrient absorption 26 may lead to undesired metabolic side-effects. Surgery for weight-loss is becoming 27 increasingly common; in 2012/13 over 8000 procedures were performed on the NHS.
[4] 28
Consequently the cohort of patients at risk of long-term metabolic side-effects of bariatric 29 surgery is growing all the time. 30
Evidence of numerous metabolic changes after bariatric surgery is accumulating and data on 31 associated clinical implications are becoming available. These include an impact on bone 32 metabolism, leading to metabolic bone disease, with consequences such as pathological 33 bone fracture. This review aims to summarize the basic science of bone metabolism, the 34 background science underpinning metabolic bone disease and relate this to the nutritional 35 sequelae of bariatric surgery. Recommended monitoring and management strategies from 36 professional organisations will then be presented to inform the best practice. 37
Low serum levels of calcium stimulate release of parathyroid hormone (PTH). This 48 stimulates increased osteoclast activity, increased bone resorption and release of calcium 49 into the circulation together with production of calcitriol. [6, 8, 9 ] 50
Vitamin D 51
In addition to the roles outlined above vitamin D acts to maintain calcium homeostasis by 52 modulating osteoblast activity and bone mineralisation. The modality used to achieve weight loss also seems to impact on whether BMD is affected. 148
Whilst caloric restriction-induced weight loss has been observed to be a risk factor for rapid 149 bone loss, physical activity-induced weight loss preserves BMD.
[37] 150
Overview of Bariatric Surgery
151
Bariatric surgery is typically classed as restrictive, malabsorptive, or a hybrid procedure. 152
Restrictive simply reduce food and calorie intake to drive weight loss. Malabsorptive 153 procedures decrease the absorptive surface available in the intestine by bypassing 154 segments reducing the amount of calories the body is able to absorb from food. Examples of 155 the different types of procedures are shown in Table 1 . 156
In general the more malabsorptive a procedure, the more weight loss is achieved. A meta-157 analysis revealed percentage excess body weight lost was 46% for gastric banding and 60% 158 for RYGB.
[38] In the UK, RYGB is the most commonly performed bariatric procedure, with 159 LAGB being the most common restrictive procedure. 160 Table 1 A small stomach pouch is created which is then anastomosed to the jejenum, thus restricting 215 food intake, whilst bypassing the distal stomach, duodenum and jejunum (Figure 4) . 216
The metabolic effects of this procedure are similar to subtotal gastrectomy. The operation involves laparoscopic insertion of an inflatable band, which is secured around 245 the top of the stomach, creating a small pouch (approximately 50ml) to receive food (Figure  246 1); in this way early satiety is achieved. 247
There is no disruption to the natural passage of the digestive tract and no effect on 248 absorption so nutritional deficiencies observed are generally a consequence of inadequate 249 intake. In metabolic bone disease, these vague symptoms precede pathological fracture or other 287 serious clinical sequelae so anticipation of nutritional deficiencies and prevention are key to 288 management. 289
There are examples of these unusual presentations in the literature, including a case of a 290 patient who presented with chronic pain five years post-RYGB and was diagnosed with a 291 variety of conditions, including lymphoma for which she received chemotherapy, which in 292 retrospect were more likely due to metabolic bone disease.
[17] 293 Impact on bone disease 294
As bariatric surgery is a relatively recent innovation, there are limited follow up data 295 regarding the incidence of long-term sequelae such as pathological bone fracture. However 296 a cohort study has demonstrated that gastrectomy with Billroth II reconstruction, which has 297 similar metabolic effects to a RYGB, has a 3.6-fold increased risk of vertebral fracture 298 compared with community residents.
[57] 299
In a study of 167 patients post-RYGB, with a mean age 47 years, found a fracture incidence 300 of 5% within a mean post-operative follow up period of 2.4 years. Given the prevalence of metabolic bone disease post-RYGB seen in this review, we suggest 398 more regular and thorough surveillance for metabolic bone disease in these patients. 399 
